Universidade Federal de Santa Maria   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Santa Maria Brazil (1960)

Organization Overview

First Clinical Trial
2009
NCT02128633
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Universidade Federal de Santa Maria

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cholecystolithiasis (Phase 4)

Cholelithiasis (Phase 4)

Coinfection (Phase 3)

Dental Plaque (Phase 4)

Dentin Sensitivity (Phase 3)

Gallstones (Phase 4)

Hypersensitivity (Phase 3)

Neuralgia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 13